NCT00211900View on ClinicalTrials.gov

Evaluation of Manufacturing Lot of StaphVAX

PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

August 31, 2005

Study Completion Date

November 30, 2005

Conditions
Staphylococcal InfectionsChronic Kidney Failure
Interventions
BIOLOGICAL

S. aureus Type 5 & 8 Capsular Polysaccharide Vaccine

single IM dose totalling 200 mcg of conjugate

Trial Locations (1)

35758

Trialogic Research, Madison

Sponsors
All Listed Sponsors
lead

Nabi Biopharmaceuticals

INDUSTRY

NCT00211900 - Evaluation of Manufacturing Lot of StaphVAX | Biotech Hunter | Biotech Hunter